menu
    • menu

    Company profile for Axovia Therapeutics

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Axovia Therapeutics is dedicated to the research and development of novel AAV gene therapies that target key aspects of ciliopathies, addressing the devastating impact of the disease head-on for patients, their families, and caregivers. Axovia is currently developing therapies for patients with mutations in the BBS1 gene which manifests as Bardet Biedl Syndrome. Our initial goal is to halt the progression of BBS by targeting t...
    Axovia Therapeutics is dedicated to the research and development of novel AAV gene therapies that target key aspects of ciliopathies, addressing the devastating impact of the disease head-on for patients, their families, and caregivers. Axovia is currently developing therapies for patients with mutations in the BBS1 gene which manifests as Bardet Biedl Syndrome. Our initial goal is to halt the progression of BBS by targeting the most debilitating aspects of the neurological, metabolic, and retinal dysfunctions.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Axovia Therapeuticsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    London BioScience Innovation Centre 2 Royal College Street London NW1 0NH
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://axoviatherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/axoviatherapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Axovia Therapeutics Reveals Preclinical Data for AXV-201 at ASGCT
    Axovia Therapeutics Reveals Preclinical Data for AXV-201 at ASGCT

    15 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/15/3081986/0/en/Axovia-Therapeutics-Unveils-New-Preclinical-Data-for-AXV-201-for-Treatment-of-Genetic-Obesity-Caused-by-MC4R-Mutations-at-ASGCT.html

    GLOBENEWSWIRE
    15 May 2025
    Share Share
    Axovia Therapeutics Presents New Data for AXV-101 at ASGCT
    Axovia Therapeutics Presents New Data for AXV-101 at ASGCT

    13 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/13/3079937/0/en/Axovia-Therapeutics-Presents-New-Preclinical-Data-for-AXV-101-for-the-Treatment-of-Blindness-Associated-with-BBS-Mutations-at-ASGCT.html

    GLOBENEWSWIRE
    13 May 2025
    Share Share
    Axovia Therapeutics to Present Three Posters at ASGCT Meeting
    Axovia Therapeutics to Present Three Posters at ASGCT Meeting

    28 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/28/3069672/0/en/Axovia-Therapeutics-Announces-Three-Upcoming-Poster-Presentations-at-ASGCT.html

    GLOBENEWSWIRE
    28 Apr 2025
    Share Share
    Viralgen & Axovia Partner On Gene Therapy For Retinal Dystrophy
    Viralgen & Axovia Partner On Gene Therapy For Retinal Dystrophy

    22 Jan 2025

    // PR NEWSWIRE

    https://prnewswire.com/news-releases/viralgen-and-axovia-partner-to-manufacture-an-investigational-gene-therapy-for-retinal-dystrophy-in-bardet-biedl-syndrome-bbs-patients-302357167.html

    PR NEWSWIRE
    22 Jan 2025
    Share Share
    A Race Against Blindness Grants $1 Million to Axovia for BBS
    A Race Against Blindness Grants $1 Million to Axovia for BBS

    30 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/30/2971660/0/en/A-Race-Against-Blindness-Grants-1-Million-Supporting-Axovia-Therapeutics-Planned-Clinical-Trial-for-Bardet-Biedl-Syndrome-BBS.html

    GLOBENEWSWIRE
    30 Oct 2024
    Share Share
    Rhythm And Axovia Announce Collaboration In Bardet-Biedl Syndrome
    Rhythm And Axovia Announce Collaboration In Bardet-Biedl Syndrome

    24 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/10/24/2968482/0/en/Rhythm-Pharmaceuticals-and-Axovia-Therapeutics-Announce-Joint-Research-Collaboration-in-Bardet-Biedl-Syndrome.html

    GLOBENEWSWIRE
    24 Oct 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search